Explore

Trendline Trendline
Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments
Trendline Trendline
Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments
Trendline Trendline
AN2 Therapeutics Reports Q1 2026 Financial Results and Pipeline Updates

AN2 Therapeutics Reports Q1 2026 Financial Results and Pipeline Updates

AN2 Therapeutics Reports Q1 2026 Financial Results and Pipeline Updates
Trendline Trendline
Anteris Technologies Reports Q1 2026 Financial Results with Increased Net Loss

Anteris Technologies Reports Q1 2026 Financial Results with Increased Net Loss

Anteris Technologies Reports Q1 2026 Financial Results with Increased Net Loss
Trendline Trendline
enGene Faces Stock Plunge Amid Declining Response Rates in Bladder Cancer Therapy

enGene Faces Stock Plunge Amid Declining Response Rates in Bladder Cancer Therapy

enGene Faces Stock Plunge Amid Declining Response Rates in Bladder Cancer Therapy
Trendline Trendline
Adagio Medical Reports Q1 2026 Financial Results and Clinical Progress

Adagio Medical Reports Q1 2026 Financial Results and Clinical Progress

Adagio Medical Reports Q1 2026 Financial Results and Clinical Progress
Trendline Trendline
Turn Therapeutics Reports Q1 2026 Financial Results and Corporate Updates

Turn Therapeutics Reports Q1 2026 Financial Results and Corporate Updates

Turn Therapeutics Reports Q1 2026 Financial Results and Corporate Updates
Trendline Trendline
Nika Pharmaceuticals Reports First-Quarter 2026 Financial Results Indicating Continued Net Loss

Nika Pharmaceuticals Reports First-Quarter 2026 Financial Results Indicating Continued Net Loss

Nika Pharmaceuticals Reports First-Quarter 2026 Financial Results Indicating Continued Net Loss
Trendline Trendline
Verastem Oncology to Present at Key Investor Conferences in May 2026

Verastem Oncology to Present at Key Investor Conferences in May 2026

Verastem Oncology to Present at Key Investor Conferences in May 2026
Trendline Trendline
Nika Pharmaceuticals Reports First-Quarter 2026 Financial Results with Net Loss

Nika Pharmaceuticals Reports First-Quarter 2026 Financial Results with Net Loss

Nika Pharmaceuticals Reports First-Quarter 2026 Financial Results with Net Loss
Trendline Trendline
Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call
Trendline Trendline
Omeros Corporation to Release First Quarter 2026 Financial Results and Host Conference Call

Omeros Corporation to Release First Quarter 2026 Financial Results and Host Conference Call

Omeros Corporation to Release First Quarter 2026 Financial Results and Host Conference Call